Answers are grounded in this paper and cite their sources.
The most common cancer in childhood is now curable in 90% of patients. Current efforts are focused on devising molecular-based therapy for the subsets of acute lymphoblastic leukemia that are most resistant to current therapy.
No takes yet. Share an insight, caveat, or question.
Hunger et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: